High throughput metabolic stability screen for lead optimization in drug discovery

被引:11
|
作者
Tong, XCS [1 ]
Xu, SY [1 ]
Zheng, S [1 ]
Pivnichny, JV [1 ]
Martin, J [1 ]
Dufresne, C [1 ]
机构
[1] Merck & Co Inc, Merck Res Lab, Basic Chem, Rahway, NJ 07065 USA
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2006年 / 833卷 / 02期
关键词
high throughput; metabolic stability; automation;
D O I
10.1016/j.jchromb.2006.01.037
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A high throughput approach for the determination of in vitro metabolic stability and metabolic profiles of drug candidates has been developed. This approach comprises the combination of a Biomek FX liquid handling system with 96-channel pipetting capability and a custom-designed 96-well format on-line incubator with efficient thermal conductivity. This combination facilitates automated reagent preparation, sample incubation, and sample purification for rnicrosome stability studies. The overall process is both fast and accurate and meets the challenges of high throughput screening for drug discovery. A custom designed, user-friendly computer program has been incorporated for large-scale data processing and report generation. Several applications are discussed that implement this strategy for rapid selection of compounds in early drug discovery. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:165 / 173
页数:9
相关论文
共 50 条
  • [1] A High-Throughput Screen for Antibiotic Drug Discovery
    Scanlon, Thomas C.
    Dostal, Sarah M.
    Griswold, Karl E.
    BIOTECHNOLOGY AND BIOENGINEERING, 2014, 111 (02) : 232 - 243
  • [2] High-throughput crystallography for lead discovery in drug design
    Blundell, TL
    Jhoti, H
    Abell, C
    NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (01) : 45 - 54
  • [3] High-throughput crystallography for lead discovery in drug design
    Tom L. Blundell
    Harren Jhoti
    Chris Abell
    Nature Reviews Drug Discovery, 2002, 1 : 45 - 54
  • [4] Drug metabolic stability in early drug discovery to develop potential lead compounds
    Gajula, Siva Nageswara Rao
    Nadimpalli, Nimisha
    Sonti, Rajesh
    DRUG METABOLISM REVIEWS, 2021, 53 (03) : 459 - 477
  • [5] Opitimization of high throughput microsomal stability assay for drug discovery
    Di, L
    Kerns, E
    Hong, Y
    Kleintop, T
    McConnell, O
    Huryn, D
    DRUG METABOLISM REVIEWS, 2003, 35 : 91 - 91
  • [6] Applications of high throughput microsomal stability assay in drug discovery
    Di, Li
    Kerns, Edward H.
    Ma, Xuewen Joann
    Huang, Youping
    Carter, Guy T.
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2008, 11 (06) : 469 - 476
  • [7] Metabolic stability screen for drug discovery using cassette analysis and column switching
    Halladay, Jason Steven
    Wong, Susan
    Merchant, Sharmin
    Khojasteh-Bakht, S. Cyrus
    Sinhababu, Achintya
    DRUG METABOLISM REVIEWS, 2006, 38 : 149 - 149
  • [8] High-throughput drug design and lead optimization with PlayMolecule
    Chevalier, Franck
    De Fabritiis, Gianni
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
  • [9] Pitfalls in high throughput screening for. drug absorption optimization in drug discovery
    Komura, Hiroshi
    Iwaki, Masahiro
    CURRENT ANALYTICAL CHEMISTRY, 2007, 3 (04) : 302 - 309
  • [10] Application of in vitro high throughput metabolic stability experiments to predict in vivo clearance and decision making in drug discovery
    Fisher, A
    Dong, T
    Yuan, ZD
    Sai, Y
    Wen, J
    Chen, TK
    Song, N
    Zou, ZYZ
    Bozigian, HP
    Madan, A
    DRUG METABOLISM REVIEWS, 2003, 35 : 91 - 91